Global Oncology Launches Global Cancer Project Map To Improve Cancer Control Worldwide in Collaboration with NCI
Nonprofit Global Oncology GO) has launched the Global Cancer Project Map, a first-of-its-kind online resource and virtual information exchange for connecting the global cancer community. Developed by GO in collaboration with the National Cancer Institute (NCI) Center for Global Health, the Map enables worldwide access to cancer projects and expertise to improve cancer practices and patient outcomes, especially in low-resource settings.
The Map was unveiled at the Symposium on Global Cancer Research, which is sponsored by NCI, the Consortium of Universities for Global Health (CUGH), and the Dana-Farber Cancer Institute, and is taking place in Boston, MA.
GO developed the Global Cancer Project Map to fill a crucial need for shared resources: According to the World Bank, only 5% of global health funding for cancer is committed to oncology in developing countries. This number stands even though Africa, Asia, and Central and South America account for 60% of the world’s new cancer diagnoses and 70% of the world’s cancer deaths, according to the World Health Organization.
“The Map is an important and innovative step forward in our effort to reduce health disparities and strengthen human capital in underserved areas of the world,” said Michele Barry Director of Stanford University’s Center for Innovation in Global Health. “With cancer rates rapidly increasing in low-resource settings, the Map creates a place where the global cancer community can share and access information that is critical to providing better treatment and care.”
The Global Cancer Project Map is an interactive online database that allows users to search for cancer experts and research projects by country and by cancer type, and then to initiate contact with project principal investigators and programme directors. The Map launched with more than 700 projects spanning six continents. The goal is for the Map to grow exponentially as awareness builds and an online tool is added in late 2015 allowing users to upload projects directly.
The Global Cancer Project Map covers a wide range of projects, from cancer prevention and screening to capacity training, clinical programs and palliative care. Illustrative projects include
• Improving diagnostic accuracy of mammograms for breast cancer in Turkey through new methods
• Preventing arsenic-induced skin cancer in Bangladesh through the study of vitamin E and selenium supplementation
• Creating an early screening test for gastric cancer in Mexico through biomarker identification leading to an early screening test.
According to Dr Ted Trimble, director of NCI’s Center for Global Health, though many dedicated researchers and caregivers are conducting groundbreaking cancer programmes around the world, until today they could not reference the collective knowledge and experiences of their colleagues in one central place. The Global Cancer Project Map has been highly anticipated in the cancer community and will make a significant impact in cancer patient care and global health.
“Before it was difficult or often impossible to find information about cancer projects or experts, especially in resource-limited settings,” said GO co-founder Ami S. Bhatt, Assistant Professor, Stanford University. “The Map now makes it possible to connect colleagues in the global cancer community with a maximum of six clicks of a computer mouse.”
“We have the ambitious goal of providing access to every cancer research, care, and outreach programme in the world through the Map,” said GO co-founder Franklin W. Huang, Instructor at Dana-Farber Cancer Institute and Harvard Medical School. “GO encourages anyone working in cancer to use the Map to get and give valuable information about their projects, contributing to cancer care for patients no matter where they are.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.